These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7466744)

  • 1. Potential hazards of antifibrinolytic treatment in subarachnoid haemorrhage.
    Levati A; Minella C; Farina ML; D'Angelo V
    Thromb Haemost; 1980 Dec; 44(3):170. PubMed ID: 7466744
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial infarction during antifibrinolytic treatment of subarachnoid haemorrhage.
    Farina ML; Levati A; Paino R
    Thromb Haemost; 1979 Dec; 42(4):1347-8. PubMed ID: 542940
    [No Abstract]   [Full Text] [Related]  

  • 3. High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage.
    Glick R; Green D; Ts'ao C; Witt WA; Yu AT; Raimondi AJ
    Neurosurgery; 1981 Oct; 9(4):398-401. PubMed ID: 7301085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of epsilon-aminocaproic acid on hemocoagulation in subarachnoid hemorrhage. Preliminary study].
    Kadanka Z; Novotný O; Penka M
    Cesk Neurol Neurochir; 1986 Sep; 49(5):320-4. PubMed ID: 3779870
    [No Abstract]   [Full Text] [Related]  

  • 5. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy.
    Woo KS; Tse LK; Woo JL; Vallance-Owen J
    Br J Clin Pract; 1989 Dec; 43(12):465-6. PubMed ID: 2611113
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous thrombosis of an intracranial aneurysm during treatment with epsilon aminocaproic acid.
    Scott RM; Garrido E
    Surg Neurol; 1977 Jan; 7(1):21-3. PubMed ID: 831307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anaphylactic shock in response to the administration of epsilon-aminocaproic acid].
    Kazanbiev NK; Akhmedova DA; Gasanova RG; Bagamedov MM; Sfiev AA
    Klin Med (Mosk); 1987 Oct; 65(10):140-1. PubMed ID: 3431047
    [No Abstract]   [Full Text] [Related]  

  • 8. Myopathy due to epsilon amino-caproic acid.
    Kennard C; Swash M; Henson RA
    Muscle Nerve; 1980; 3(3):202-6. PubMed ID: 6990256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Arteritis due to EACA therapy.
    Hood RS; Sonntag VK; Stein BM
    J Neurosurg; 1975 Jan; 42(1):117-8. PubMed ID: 1110384
    [No Abstract]   [Full Text] [Related]  

  • 10. Epsilon aminocaproic acid myopathy.
    Britt CW; Schochet SS
    Muscle Nerve; 1981; 4(3):256. PubMed ID: 7242563
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preoperative care and treatment of acute subarachnoid hemorrhage].
    Rehák S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1987; 30(2):241-6. PubMed ID: 3504596
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of intraperitoneal haemorrhage with antifibrinolytic therapy in a patient with ovarian carcinoma.
    Marsland T; Griffin T; Ansell J; Hunter R
    Thromb Haemost; 1981 Aug; 46(2):566. PubMed ID: 7302894
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of subarachnoid hemorrhage: the ability of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity.
    Levy BJ; Silver D
    Surg Forum; 1968; 19():413-4. PubMed ID: 5718686
    [No Abstract]   [Full Text] [Related]  

  • 14. EACA and subarachnoid hemorrhage.
    Smith RR
    J Neurosurg; 1981 Jan; 54(1):135-6. PubMed ID: 7007587
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute rhabdomyolysis during treatment with epsilon aminocaproic acid. Description of two cases.
    Luliri P; Bobbio-Pallavicini E; Gorini M
    Haematologica; 1983; 68(5):664-9. PubMed ID: 6416944
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute delirious state after epsilon-amino caproic acid administration.
    Wysenbeek AJ; Sella A; Blum I; Yeshurun D
    Clin Toxicol; 1979; 14(1):93-5. PubMed ID: 436386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage.
    Kalmadi S; Tiu R; Lowe C; Jin T; Kalaycio M
    Cancer; 2006 Jul; 107(1):136-40. PubMed ID: 16708357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intrathecal administration of antifibrinolytics in primary subarachnoid hemorrhage during the acute period].
    Leska P; Krupka J; Nakládal J; Volcík P
    Cesk Neurol Neurochir; 1987 Jan; 50(1):17-23. PubMed ID: 3492295
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications during subarachnoid hemorrhage in relation to antifibrinolytic treatment].
    Kadanka Z; Hrazdira CL; Pellar M
    Cesk Neurol Neurochir; 1984 May; 47(3):164-8. PubMed ID: 6467413
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasminogen depletion during administration of epsilon-aminocarproic acid.
    Nibbelink DW; Jacobsen CD
    Thromb Diath Haemorrh; 1973 Jun; 29(3):598-602. PubMed ID: 4761827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.